Protagonist Therapeutics Target Price

Analysts' average 12-month price target for Protagonist Therapeutics is $170.

Get informed when a big investor buys or sells

+ Follow

Share Price

$140.06

Average Target Price

$169.18

20.8% upside

11 analysts in the last 4 months

High: $190 | Low: $145

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-01	BMO CapitalEvan Seigerman	$190	35.7% upside
2026-09-01	BarclaysEtzer Darout	$180	28.5% upside
2026-08-31	H.C. Wainwright	$170	21.4% upside
2026-08-17	BMO Capital	$178	27.1% upside
2026-08-10	Truist FinancialSrikripa Devarakonda	$170	21.4% upside
2026-08-10	Wedbush	$173	23.5% upside
2026-08-10	Goldman SachsRichard Law	$186	32.8% upside
2026-08-06	Barclays	$153	9.2% upside
2026-07-17	Johnson Rice	$165	17.8% upside
2026-07-14	Barclays	$151	7.8% upside
2026-07-07	Truist Financial	$145	3.5% upside
2026-05-06	Goldman Sachs	$110	21.5% downside
2026-04-14	Truist FinancialSrikripa Devarakonda	$121	13.6% downside
2026-03-18	JefferiesRoger Song	$121	13.6% downside
2026-01-30	H.C. Wainwright	$117	16.5% downside
2026-01-05	Truist Financial	$110	21.5% downside
2025-12-17	Barclays	$108	22.9% downside
2025-10-28	Truist FinancialSrikripa Devarakonda	$88	37.2% downside
2025-10-13	Johnson Rice	$112	20% downside
2025-10-07	Johnson Rice	$74	47.2% downside
2025-09-16	Barclays	$72	48.6% downside
2025-03-11	Wedbush	$70	50% downside
2025-03-11	Truist Financial	$76	45.7% downside
2025-03-03	BTIG	$73	47.9% downside
2024-12-05	BMO CapitalEtzer Darout	$62	55.7% downside
2024-11-22	Truist FinancialSrikripa Devarakonda	$60	57.2% downside
2024-09-12	H.C. WainwrightDouglas Tsao	$50	64.3% downside
2024-06-17	H.C. WainwrightDouglas Tsao	$38	72.9% downside

Protagonist Therapeutics (PTGX) FAQ

The latest target price for PTGX is $170. Investors often review this figure alongside Protagonist Therapeutics's historical trend and sector peers before judging valuation or financial health.

Protagonist Therapeutics trades near $140.06 while the consensus target sits at $170 (20.8% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting PTGX's target price ($170), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Protagonist Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.